IMS Young Investigator Award
Through the IMS Young Investigator Awards, the International Myeloma Society provides travel grants to young myeloma researchers to assist with expenses relating to their participation at the International Myeloma Society Annual Meeting. The IMS Executive Committee will decide, according to the scores of the abstracts and the quality of presentation, which investigators receive a travel grant.
Eligibility:
Eligible applicants must be:
- Age 35 years or younger
- Registered at the IMS Annual Meeting
- Have an Abstract selected for oral or poster presentation at International Myeloma Society Annual Meeting. The award winner must be the primary author on the submitted Abstract.
Application Evaluation
Each eligible application will be reviewed by the current Annual Meeting abstract reviewers. The best abstracts are then sent to members of the International Myeloma Society (IMS) Executive Committee.
Award Amount
The awardee will receive up to $2,000 US dollars to offset travel expenses. IMS is committed to providing travel support assistance to its members through society resources and through external grant support. Because external funding is not guaranteed, the extent of travel support available is unknown at this time.
Meeting Event
The award recipient will be recognized at the current year International Myeloma Society Annual Meeting
Award Terms
- The awardee will receive up to $2,000 US dollars from the IMS.
- The recipient is asked to cite support from the International Myeloma Society (IMS) in any publication resulting from the abstract data.
- Abstracts will be published in an e-book supplement of Elsevier “Clinical Lymphoma, Myeloma, and Leukemia” review.
Questions
If you have any questions or require additional information regarding the IMS Young Investigator Award please contact adminassistant@myelomasociety.org.
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
